CIK 0002044725 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Evommune, Inc.
Sign in to watch- Ticker
- EVMN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850742575
- Phone
- (650) 223-7745
- Business address
- 1891 PAGE MILL RD, PALO ALTO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-07 | Pivotal bioVenture Partners Fund I, L.P. Director | Conversion · Series C Preferred Stock | −2,508,575 | 0 | ||
| 2025-11-05 | Patel Jeegar Pravinkumar Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +179,619 | 179,619 | ||
| 2025-11-05 | Drew Janice Suzann EVP, Operations | Grant or award · Employee Stock Option (Right to Buy) | +231,274 | 231,274 | ||
| 2025-11-05 | Carver Kyle Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +279,408 | 279,408 | ||
| 2025-11-05 | Moss Gregory S. Chief Business & Legal Officer | Grant or award · Employee Stock Option (Right to Buy) | +293,496 | 293,496 | ||
| 2025-11-05 | Pena Luis C. President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +796,841 | 796,841 | ||
| 2025-11-05 | Cohen David E Director | Grant or award · Stock Option (Right to Buy) | +37,960 | 37,960 | ||
| 2025-11-05 | KIRSCH ARTHUR S Director | Grant or award · Stock Option (Right to Buy) | +37,960 | 37,960 | ||
| 2025-11-05 | MCGRAW BENJAMIN F III Director | Grant or award · Stock Option (Right to Buy) | +37,960 | 37,960 |
Page 6 of 6 · 109 trades